Uptake of new antidiabetic medicines in 11 European countries

BACKGROUND: Several new antidiabetic medicines (GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors) have been approved by the European Medicines Agency since 2006. The aim of this study was to evaluate the uptake of new antidiabetic medicines in European countries over a 10-year period...

Descripción completa

Detalles Bibliográficos
Autores principales: Mardetko, Nika, Nabergoj Makovec, Urska, Locatelli, Igor, Janez, Andrej, Kos, Mitja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235847/
https://www.ncbi.nlm.nih.gov/pubmed/34172020
http://dx.doi.org/10.1186/s12902-021-00798-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235847/
https://www.ncbi.nlm.nih.gov/pubmed/34172020
http://dx.doi.org/10.1186/s12902-021-00798-3

Ejemplares similares